Photobiomodulation and Chronic Diabetic Foot Ulcers (Clinical Trial – NCT05116605)
Share
This clinical trial evaluated the effectiveness of photobiomodulation (PBM) as a treatment for chronic diabetic foot ulcers (DFUs). The study aimed to determine whether PBM could improve wound healing outcomes when used alongside conventional diabetic wound care.
The trial focused on assessing PBM’s potential to accelerate wound closure, improve tissue repair, reduce inflammation, and support healing in chronic ulcers, which are a common and serious complication of diabetes. PBM is being investigated because of its non-invasive effects on circulation, cellular metabolism, and regenerative processes.
Researchers monitored wound-healing progression and treatment response to evaluate whether PBM could serve as a supportive therapy for improving recovery in difficult-to-heal diabetic wounds. The broader goal was to assess its clinical value and safety in chronic ulcer management.
Key takeaway: This trial supports ongoing investigation into PBM as a non-invasive adjunct therapy for diabetic foot ulcers, with focus on wound healing, tissue regeneration, and chronic wound management.
https://clinicaltrials.gov/study/NCT05116605